The identification of pharmaceutical impurities is a critical analytical activity in the drug development process. The aim is to fully elucidate the chemical structures of unknown pharmaceutical impurities present above a certain concentration in medicinal substances and products. 

Mérieux NutriSciences - Pharma e dispositivi medici - Identificazione delle impurità sconosciute

Knowledge of the chemical structure of an impurity is essential in order to assess the toxicological implications and to gain an understanding of how the impurity formed. Furthermore, knowledge of the formation mechanism is critical for improving the synthetic chemical processes and optimizing the drug’s formulation to reduce or eliminate the impurity.
Mérieux NutriSciences proposes strategies for the identification of pharmaceutical impurities using various approaches and instruments, including: 

  • LC‐ HRMS
  • GC‐HRMS
  • 1H /13C - NMR

 

You might be also interested in:

December 2nd, 2021
Market News , Local News
  Recently, FDA is pushing to investigate the presence of certain types of nitrosamine impurities - formed in several drug products. These nitrosamine drug substance-related impuritie...
December 2nd, 2021
Market News , Local News
  In March, together with the Department of Pathophysiology and Transplantation’ researchers -University of Milan-, ECSIN LAB published a new article entitled “Capryloyl glycine and soy is...